Καναδάς - Αγγλικά - Health Canada

apotex inc - atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 80mg - atorvastatin (atorvastatin calcium propylene glycol solvate) 80mg - hmg-coa reductase inhibitors

Καναδάς - Αγγλικά - Health Canada

sivem pharmaceuticals ulc - atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg - atorvastatin (atorvastatin calcium propylene glycol solvate) 10mg - hmg-coa reductase inhibitors

Καναδάς - Αγγλικά - Health Canada

sivem pharmaceuticals ulc - atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 20mg - atorvastatin (atorvastatin calcium propylene glycol solvate) 20mg - hmg-coa reductase inhibitors

Καναδάς - Αγγλικά - Health Canada

sivem pharmaceuticals ulc - atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 40mg - atorvastatin (atorvastatin calcium propylene glycol solvate) 40mg - hmg-coa reductase inhibitors

Καναδάς - Αγγλικά - Health Canada

sivem pharmaceuticals ulc - atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 80mg - atorvastatin (atorvastatin calcium propylene glycol solvate) 80mg - hmg-coa reductase inhibitors

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; microcrystalline cellulose; sodium starch glycollate; magnesium stearate - hypertension: first line treatment of hypertension. it can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine besylate, which has been used in combination with a thiazide diuretic, beta-adrenoreceptor blocking agent, or an angiotensin converting enzyme inhibitor. angina: first line treatment of chronic stable angina. amlodipine besylate may be used alone, as monotherapy, or in combination with other antianginal drugs.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; sodium starch glycollate; magnesium stearate; microcrystalline cellulose - hypertension: first line treatment of hypertension. it can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine besylate, which has been used in combination with a thiazide diuretic, beta-adrenoreceptor blocking agent, or an angiotensin converting enzyme inhibitor. angina: first line treatment of chronic stable angina. amlodipine besylate may be used alone, as monotherapy, or in combination with other antianginal drugs.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 20 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to: in adult patients with type 2 diabetes, and without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as retinopathy, albuminuria, smoking, or hypertension, atorvastatin

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 10 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to:  - reduce the risk of myocardial infarction     - reduce the risk of stroke     - reduce the risk for revascularization procedures and angina in patients with type 2 diabetes, and without clinically evident coronary heart dise

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

st marys medical park pharmacy - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 10 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to: - reduce the risk of myocardial infarction - reduce the risk of stroke - reduce the risk for revascularization procedures and angina in patients with type 2 diabetes, and without clinically evident coronary heart disease, but